30-Days Cardiovascular In-Hospital Mortality After Heart Valve Intervention: A Real-World Data Analysis in Italy
Author(s)
Sciattella P, Mennini FS
Economic Evaluation and HTA (EEHTA CEIS), Department of Economics and Finance, Faculty of Economics, University of Rome “Tor Vergata”, Rome, Italy
Presentation Documents
OBJECTIVES: To estimate 30-day cardiovascular in-hospital mortality (CIHM) in patients who underwent heart valve surgery versus transcatheter therapy, using the Hospital Information System (HIS) of Italy. METHODS: From HIS, which collects information related to all discharges from public and private hospitals in Italy, we identified all patients aged ≥18 years undergoing single heart valve intervention (aortic/AV-population or mitral/MV-population) between January 2017 and November 2018. For patients with multiple hospital admissions, only the first one was considered (index-event). According to the type of intervention, subjects were classified into two groups: traditional surgery (TS) and transcatheter approach (TA). 30-day CIHM was evaluated considering index and subsequent hospitalizations with main diagnosis of circulatory system diseases. Patient clinical history was defined by retrieving comorbidities recorded during hospitalizations in the 2 years before the index-event. The association between intervention and outcome was assessed using logistic models [Odds Ratio (OR)] and adjusting for age, sex and the risk factors selected by a stepwise bootstrap procedure. RESULTS: 37,687 subjects were selected for AV-population (58.2% men, mean age 72.6 years): 29,004 (77.0%) undergoing TS and 8,683 (23.0%) TA. 30-day CIHM was 3.3% for TS patients and 2.2% for TA patients, (OR 0.64; 95%CI 0.55-0.75). Multivariate analysis confirmed a reduction of mortality for patients undergoing TA (ORadj 0.52; 95%CI 0.43-0.61). For MV-population, 15,340 patients were identified (60.0% men, mean age 65.5 years), of whom 13,711 (89.4%) undergoing TS surgery and 1,629 (10.6%) TA. A reduction of 30-day CIHM for TA patients (2.3% vs 3.3%) was confirmed in both the univariate (OR 0.71; 95%CI 0.50-0.98) and multivariate model (ORadj 0.50; 95%CI 0.35‑0.70). CONCLUSIONS: The study, based on Italian administrative databases, allowed to estimate the in-hospital mortality for patients with aortic and mitral heart valve disorders, highlighting a significant association between outcome and treatment strategy.
Conference/Value in Health Info
2021-11, ISPOR Europe 2021, Copenhagen, Denmark
Value in Health, Volume 24, Issue 12, S2 (December 2021)
Code
POSB406
Topic
Clinical Outcomes
Topic Subcategory
Comparative Effectiveness or Efficacy
Disease
Cardiovascular Disorders, Surgery